Use of misoprostol in pregnancy.
Hale
R W
RW
Zinberg
S
S
D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D000028:Abortion, Induced / Q000379:methods; D020070:Cervical Ripening / Q000187:drug effects*; D004345:Drug Industry; D004348:Drug Labeling; D005260:Female; D033161:Government Regulation; D006176:Gynecology; D006801:Humans; D007751:Labor, Induced / Q000379:methods*; D015735:Mifepristone; D016595:Misoprostol / Q000627:therapeutic use*; D009774:Obstetrics; D010120:Oxytocics / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D037841:Pregnant People; D012955:Societies, Medical; D014481:United States
D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D010120:Oxytocics; D016595:Misoprostol; D015735:Mifepristone